119Sb - A potent Auger emitter for targeted radionuclide therapy

Medical Physics

Volumn 35, Issue 9, 2008, Pages 3839-3846

  Thisgaard, H ^a   Jensen, M ^a  

^a NONE

Author keywords

Auger electrons; Cancer; Jaszczak phantom; Planar scintigraphy; Production yield; Radionuclide therapy; S values; Sb 117; Sb 119; SPECT

Indexed keywords

AUGER ELECTRON SPECTROSCOPY; AUGERS; DISEASES; DOSIMETRY; NUCLEAR MEDICINE; PHANTOMS; PROTON IRRADIATION; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

AUGER ELECTRON; CANCER; PLANAR SCINTIGRAPHY; PRODUCTION YIELD; RADIONUCLIDE THERAPY; S VALUES; SPECT;

RADIOISOTOPES;

ANTIMONY 199; ANTIMONY DERIVATIVE; RADIOISOTOPE; UNCLASSIFIED DRUG; ANTIMONY; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYCLOTRON; DOSE CALCULATION; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ELECTRON; HUMAN; IMAGE QUALITY;

ANTIMONY; ELECTRONS; HUMANS; PHANTOMS, IMAGING; RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 50449108120     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2963993     Document Type: Article

References (35)

1. E. Janson, " Nuclear localization of In-111 after intravenous injection of [In-111-DTPA-D-Phe(1)]-octreotide in patients with neuroendocrine tumors.," J. Nucl. Med. 41, 1514-1518 (2000).
2. A. Capello, " Peptide receptor radionuclide therapy in vitro using [In-111-DTPA(0)]octreotide.," J. Nucl. Med. 44, 98-104 (2003).
3. R. Michel, M. Brechbiel, and M. Mattes, " A comparison of 4 radionuclides conjugated to antibodies for single-cell kill.," J. Nucl. Med. 44, 632-640 (2003).
4. T. Behr, " Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.," Eur. J. Nucl. Med. 27, 753-765 (2000).
5. R. O'Donnell, " Nuclear localizing sequences: An innovative way to improve targeted radiotherapy.," J. Nucl. Med. 47, 738-739 (2006).
6. P. Chen, " Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with In-111 in human myeloid leukemia cells.," J. Nucl. Med. 47, 827-836 (2006).
7. D. L. Costantini, " 111In-labeled Trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): An auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.," J. Nucl. Med. 48, 1357-1368 (2007).
8. R. Howell, " Radiation spectra for Auger-electron emitting radionuclides-Report No. 2 of Aapm-Nuclear-Medicine-Task-Group No. 6.," Med. Phys. 19, 1371-1383 (1992).
9. A. Kassis, " Cancer therapy with Auger electrons: Are we almost there?," J. Nucl. Med. 44, 1479-1481 (2003).
10. S. Govindan, " Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: Comparison of Auger electron emitters with beta-particle emitters.," J. Nucl. Med. 41, 2089-2097 (2000).
11. A. Kassis, " The amazing world of Auger electrons.," Int. J. Radiat. Biol. 80, 789-803 (2004).
12. S. Adelstein, " Radiotoxicity of iodine-125 and other Auger-electron-emitting radionuclides: Background to therapy.," Cancer Biother. Radiopharm. 18, 301-316 (2003).
13. R. Howell and A. Bishayee, " Bystander effects caused by nonuniform distributions of DNA-incorporated I-125.," Micron 33, 127-132 (2002).
14. G. Griffiths, " Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies.," Int. J. Cancer 81, 985-992 (1999).
15. M. Mattes, " Radionuclide-antibody conjugates for single-cell cytotoxicity.," Cancer 94, 1215-1223 (2002).
16. F. Rosch, " Uptake kinetics of the somatostatin receptor ligand [Y-86] DOTA-DPhe(1)-Tyr(3)-octreotide ([Y-86] SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the Y-90-labelled analogue.," Eur. J. Nucl. Med. 26, 358-366 (1999).
17. H. Herzog, " Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with pet and radiation-dose calculation of analogous Y-90 radiotherapeutics.," J. Nucl. Med. 34, 2222-2226 (1993).
18. A. Helisch, " Pre-therapeutic dosimetry and biodistribution of Y-86-DOTA-Phe(1)-Tyr(3)-octreotide versus In-111-pentetreotide in patients with advanced neuroendocrine tumours.," Eur. J. Nucl. Med. Mol. Imaging 31, 1386-1392 (2004).
19. K. Kolbert, " Prediction of absorbed dose to normal organs in thyroid cancer patients treated with I-131 by use of I-124 PET and 3-dimensional internal dosimetry software.," J. Nucl. Med. 48, 143-149 (2007).
20. G. Sgouros, " Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software.," J. Nucl. Med. 45, 1366-1372 (2004).
21. S. Goddu, MIRD Cellular S Values (Society of Nuclear Medicine, Reston, Virginia, 1997).
22. M. J. Berger, " Beta-ray dosimetry calculations with the use of point kernels.," Medical Radionuclides: Radiation Dose and Effects, AEC Symposium Series No. 20, edited by, R. J. Cloutier, C. L. Edwards, and, W. S. Snyder, US Atomic Energy Commission, pp. 63-86 (1970).
23. A. Cole, " Absorption of 20-Ev to 50 000-Ev electron beams in air and plastic.," Radiat. Res. 38, 7-33 (1969).
24. " Nuclear Decay Data Files for Dose Calculations. " (2001).
25. " The RAdiation dose assessment resource-RADAR.," http://www.doseinfo-radar.com/ (2005).
26. " IAEA charged-particle cross section database for medical radioisotope production.," http://www-nds.iaea.or.at/medical/ (2000).
27. " WWW table of radioactive isotopes.," http://ie.lbl.gov/toi/ (2004).
28. K. Sastry, " Electron dosimetry for radioimmunotherapy-Optimal electron-energy.," Radiat. Prot. Dosim. 13, 249-252 (1985).
29. P. Bernhardt, " Low-energy electron emitters for targeted radiotherapy of small tumours.," Acta Oncol. 40, 602-608 (2001).
30. P. Zanzonico, " Invited commentary-Model-based versus patient-specific dosimetry: Blurring the lines.," J. Nucl. Med. 43, 1665-1666 (2002).
31. S. Goddu, D. Rao, and R. Howell, " Multicellular dosimetry for micrometastases-Dependence of self-dose versus cross-dose to cell-nuclei on type and energy of radiation and subcellular-distribution of radionuclides.," J. Nucl. Med. 35, 521-530 (1994).
32. A. Kassis and S. Adelstein, " Radiobiologic principles in radionuclide therapy.," J. Nucl. Med. 46, 4S-12S (2005).
33. J. ODonoghue and T. Wheldon, " Targeted radiotherapy using Auger electron emitters.," Phys. Med. Biol. 41, 1973-1992 (1996).
34. G. Beyer, S. Zeisler, and D. Becker, " The Auger-electron emitter Er-165: Excitation function of the Ho-165(p, n)Er-165 process.," Radiochim. Acta 92, 219-222 (2004).
35. " Q-value calculator.," National Nuclear Data Center, Brookhaven National Laboratory, http://www.nndc.bnl.gov/qcalc/ (2007).